NEWS

Our Latest News

ARCHIMED’s sale of Polyplus to Sartorius Stedim earns 300x for MED I, an all-time record return for a private equity investment
ARCHIMED’s sale of Polyplus to Sartorius Stedim earns 300x for MED I, an all-time record return for a private equity investment

ARCHIMED’s sale of Polyplus to Sartorius Stedim earns 300x for MED I, an all-time record return for a private equity investment

 April

 13, 

2023

ARCHIMED completes seventh acquisition for NAMSA, the world leader in Medical Device testing services

 March

 27, 

2023

Majority owner ARCHIMED and partners CAPZA and Siparex finance add-on acquisition by European safety testing company – and French market leader – CARSO

 March

 16, 

2023

ARCHIMED buys WiQo, a pioneer in the field of aesthetic medicine

 March

 9, 

2023

ARCHIMED invests in PlasmidFactory, a German gene and cell therapy specialist

 October

 7, 

2022

ARCHIMED Impact Report 2021 – Investing for Better Healthcare: a Global Challenge

 October

 4, 

2022

1 2 3 … 12
368